References
- Mohammadi M, Meskini M, do Nascimento Pinto AL. 2019 novel coronavirus (COVID-19) overview. Z Gesundh Wiss. 2020: 1–9. doi:https://doi.org/10.1007/s10389-020-01258-3.
- Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–673. doi:https://doi.org/10.1016/j.jiph.2020.03.019.
- Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2020, StatPearls Publishing LLC; 2020.
- Lovato A, de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. 2020:145561320920762. doi:https://doi.org/10.1177/0145561320920762.
- Taherifard E, Taherifard E. Neurological complications of COVID-19: a systematic review. Neurol Res. 2020: 1–8. doi:https://doi.org/10.1080/01616412.2020.1796405.
- Kadkhoda K. COVID-19: an Immunopathological view. mSphere. 2020;5(2). doi:https://doi.org/10.1128/mSphere.00344-20.
- Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi:https://doi.org/10.1016/j.autrev.2020.102597.
- Rodríguez Y, Novelli L, Rojas M, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020. doi:https://doi.org/10.1016/j.jaut.2020.102506.
- Zulfiqar AA, Lorenzo-Villalba N, Hassler P, et al. Immune thrombocytopenic purpura in a patient with covid-19. N Engl J Med. 2020;382(18):e43. doi:https://doi.org/10.1056/NEJMc2010472.
- Hindilerden F, Yonal-Hindilerden I, Akar E, et al. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: report of a case. Thromb Res. 2020;195:136–138. doi:https://doi.org/10.1016/j.thromres.2020.07.005.
- Hindilerden F, Yonal-Hindilerden I, Akar E, et al. Severe autoimmune hemolytic anemia in COVID-19 infection, safely treated with steroids. Mediterr J Hematol Infect Dis. 2020;12(1):e2020053. doi:https://doi.org/10.4084/mjhid.2020.053.
- Huscenot T, Galland J, Ouvrat M, et al. SARS-CoV-2-associated cold agglutinin disease: a report of two cases. Ann Hematol. 2020;99(8):1943–1944. doi:https://doi.org/10.1007/s00277-020-04129-9.
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:https://doi.org/10.1186/2046-4053-4-1.
- de la Cruz-Benito B, Rivas-Pollmar MI, Álvarez Román MT, et al. Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia. Br J Haematol. 2020. doi:https://doi.org/10.1111/bjh.17077.
- Mahévas M, Moulis G, Andres E, et al. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series. Br J Haematol. 2020;190(4):e224–e2e9. doi:https://doi.org/10.1111/bjh.17024.
- Zagorski E, Pawar T, Rahimian S, et al. Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19). Br J Haematol. 2020. doi:https://doi.org/10.1111/bjh.16892.
- Patil NR, Herc ES, Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther. 2020. doi:https://doi.org/10.1016/j.hemonc.2020.06.005.
- Capes A, Bailly S, Hantson P, et al. COVID-19 infection associated with autoimmune hemolytic anemia. Ann Hematol. 2020;99(7):1679–1680. doi:https://doi.org/10.1007/s00277-020-04137-9.
- Moonla C, Watanaboonyongcharoen P, Suwanpimolkul G, et al. Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections. Clin Case Rep. 2020. doi:https://doi.org/10.1002/ccr3.3152.
- Maslov DV, Simenson V, Jain S, et al. COVID-19 and cold agglutinin hemolytic anemia. TH Open. 2020;4(3):e175–e177. doi:https://doi.org/10.1055/s-0040-1715791.
- Jensen CE, Wilson S, Thombare A, et al. Cold agglutinin syndrome as a complication of Covid-19 in two cases. Clin Infect Prac. 2020;7:100041. doi:https://doi.org/10.1016/j.clinpr.2020.100041.
- Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190(1):29–31. doi:https://doi.org/10.1111/bjh.16794.
- Lopez C, Kim J, Pandey A, et al. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. Br J Haematol. 2020;190(1):31–32. doi:https://doi.org/10.1111/bjh.16786.
- Jacobs J, Eichbaum Q. COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion. 2020. doi:https://doi.org/10.1111/trf.16226.
- Vega Hernández P, Borges Rivas Y, Ortega Sánchez E, et al. Autoimmune hemolytic anemia in a pediatric patient with severe acute respiratory syndrome coronavirus 2 infection. Pediatr Infect Dis J. 2020;39(9):e288. doi:https://doi.org/10.1097/inf.0000000000002809.
- Jawed M, Hart E, Saeed M. Haemolytic anaemia: a consequence of COVID-19. BMJ Case Rep. 2020;13(12):e238118. doi:https://doi.org/10.1136/bcr-2020-238118.
- D'Aloisio R, Nasillo V, Gironi M, et al. Bilateral macular hemorrhage in a patient with COVID-19. Am J Ophthalmology Case Rep. 2020;20:100958. doi:https://doi.org/10.1016/j.ajoc.2020.100958.
- Sereno M, Gutiérrez-Gutiérrez G, Sandoval C, et al. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: is immunosuppression a risk factor for SARS-COV2 infection? Lung Cancer (Amsterdam, Netherlands). 2020;145:213–215. doi:https://doi.org/10.1016/j.lungcan.2020.04.029.
- Wahlster L, Weichert-Leahey N, Trissal M, et al. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation. Pediatr Blood Cancer. 2020: e28382. doi:https://doi.org/10.1002/pbc.28382.
- Li M, Nguyen CB, Yeung Z, et al. Evans syndrome in a patient with COVID-19. Br J Haematol. 2020;190(2):e59–e61. doi:https://doi.org/10.1111/bjh.16846.
- Vadlamudi G, Hong L, Keerthy M. Evans syndrome associated with pregnancy and COVID-19 infection. Case Rep Obstet Gynecol. 2020;2020:8862545. doi:https://doi.org/10.1155/2020/8862545.
- Revuz S, Vernier N, Saadi L, et al. Immune thrombocytopenic purpura in patients with COVID-19. Eur J Case Rep Intern Med. 2020;7(7):001751. doi:https://doi.org/10.12890/2020_001751.
- Bennett J, Brown C, Rouse M, et al. Immune thrombocytopenia purpura secondary to COVID-19. Cureus. 2020;12(7):e9083. doi:https://doi.org/10.7759/cureus.9083.
- Bomhof G, Mutsaers P, Leebeek FWG, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020;190(2):e61–e64. doi:https://doi.org/10.1111/bjh.16850.
- Hindilerden F, Yonal-Hindilerden I, Sevtap S, et al. Immune thrombocytopenia in a very elderly patient with covid-19. Front Med (Lausanne). 2020;7:404. doi:https://doi.org/10.3389/fmed.2020.00404.
- Lorenzo-Villalba N, Zulfiqar AA, Auburtin M, et al. Thrombocytopenia in the course of COVID-19 infection. Eur J Case Rep Intern Med. 2020;7(6):001702. doi:https://doi.org/10.12890/2020_001702.
- Deruelle E, Ben Hadj Salem O, Sep Hieng S, et al. Immune thrombocytopenia in a patient with COVID-19. Int J Hematol. 2020. doi:https://doi.org/10.1007/s12185-020-02943-5.
- Lévesque V, Millaire É, Corsilli D, et al. Severe immune thrombocytopenic purpura in critical COVID-19. Int J Hematol. 2020. doi:https://doi.org/10.1007/s12185-020-02931-9.
- Merli M, Ageno W, Sessa F, et al. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection. Ann Hematol. 2020;99(8):1951–1952. doi:https://doi.org/10.1007/s00277-020-04130-2.
- Yang Y, Zhao J, Wu J, et al. A rare case of immune thrombocytopenic purpura, secondary to COVID-19. J Med Virol. 2020. doi:https://doi.org/10.1002/jmv.26051.
- Martincic Z, Skopec B, Rener K, et al. Severe immune thrombocytopenia in a critically ill COVID-19 patient. Int J Infect Dis. 2020;99:269–271. doi:https://doi.org/10.1016/j.ijid.2020.08.002.
- Humbert S, Razanamahery J, Payet-Revest C, et al. COVID-19 as a cause of immune thrombocytopenia. Med Mal Infect. 2020;50(5):459–460. doi:https://doi.org/10.1016/j.medmal.2020.05.003.
- Pedroso A, Frade L, Trevas S, et al. Immune thrombocytopenic purpura – different presentations in Two COVID-19 patients. Cureus. 2020;12(10):e11202. doi:https://doi.org/10.7759/cureus.11202.
- Nesr G, Garnett C, Bailey C, et al. Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: a case report. Br J Haematol. 2020;190(3):e146–e148. doi:https://doi.org/10.1111/bjh.16928.
- Metallidis S, Gioula G, Papaioannou M, et al. Immune thrombocytopenia in a patient recovering from COVID-19. HemaSphere. 2020;4(5):e419. doi:https://doi.org/10.1097/hs9.0000000000000419.
- Tsao HS, Chason HM, Fearon DM. Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2. Pediatrics. 2020;146(2). doi:https://doi.org/10.1542/peds.2020-1419.
- Tang MW, Nur E, Biemond BJ. Immune thrombocytopenia due to COVID-19 during pregnancy. Am J Hematol. 2020;95(8):E191–E192. doi:https://doi.org/10.1002/ajh.25877.
- Murt A, Eskazan AE, Yılmaz U, et al. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. J Med Virol. doi:https://doi.org/10.1002/jmv.26138.
- Levraut M, Ottavi M, Lechtman S, et al. Immune thrombocytopenic purpura after COVID-19 infection. Int J Lab Hematol. 2020. doi:https://doi.org/10.1111/ijlh.13346.
- Lobos P, Lobos C, Aravena P. Immune thrombocytopenic purpura associated with coronavirus disease 2019 infection in an asymptomatic young healthy patient. JAAD Case Rep. 2020;6(11):1129–1131. doi:https://doi.org/10.1016/j.jdcr.2020.08.037.
- Kewan T, Almhana F, Schwartzman L, et al. COVID-19 patient with immune thrombocytopenic purpura. Int J Lab Hematol. 2020;42(6):e260–e262. doi:https://doi.org/10.1111/ijlh.13303.
- Hayden A, Vyas-Lahar A, Rella V, et al. Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome. Lupus. 2020;29(11):1472–1474. doi:https://doi.org/10.1177/0961203320940389.
- Molinaro E, Novara E, Bonometti R, et al. Isolated immune thrombocytopenic purpura in a young adult covid-19 patient. Eur Rev Med Pharmacol Sci. 2020;24(20):10850–10852. doi:https://doi.org/10.26355/eurrev_202010_23447.
- Pascolini S, Granito A, Muratori L, et al. Coronavirus disease associated immune thrombocytopenia: causation or correlation? J Microbiol Immunol Infect. 2020. doi:https://doi.org/10.1016/j.jmii.2020.08.006.
- Soares A, Loggetto SR, Manga FCM, et al. Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient. Hematol Transfus Cell Ther. 2020. doi:https://doi.org/10.1016/j.htct.2020.09.145.
- Clerici B, Birocchi S, Bertinato E, et al. A case of newly diagnosed immune thrombocytopenia in the COVID-19 era. Intern Emerg Med. 2020: 1–5. doi:https://doi.org/10.1007/s11739-020-02553-3.
- Kondo Y, Kaneko Y, Oshige T, et al. Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis. 2020. doi:https://doi.org/10.1136/annrheumdis-2020-218157.
- Hu Z, Chen W, Liang W, et al. Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy – a case report. Ann Hematol. 2020:1–3. doi:https://doi.org/10.1007/s00277-020-04070-x.
- Albiol N, Awol R, Martino R. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19. Ann Hematol. 2020;99(7):1673–1674. doi:https://doi.org/10.1007/s00277-020-04097-0.
- Capecchi M, Mocellin C, Abbruzzese C, et al. Dramatic presentation of acquired TTP associated with COVID-19. Haematologica. 2020. doi:https://doi.org/10.3324/haematol.2020.262345.
- Sung J, Anjum S. Coronavirus disease 2019 (COVID-19) infection associated with antiphospholipid antibodies and four-extremity deep vein thrombosis in a previously healthy female. Cureus. 2020;12(6):e8408. doi:https://doi.org/10.7759/cureus.8408.
- Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:https://doi.org/10.1056/NEJMc2007575.
- Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62. doi:https://doi.org/10.1016/j.thromres.2020.04.014.
- Hossri S, Shadi M, Hamarsha Z, et al. Clinically significant anticardiolipin antibodies associated with COVID-19. J Crit Care. 2020;59:32–34. doi:https://doi.org/10.1016/j.jcrc.2020.05.017.
- Maria ATJ, Diaz-Cau I, Benejean JM, et al. Flare of antiphospholipid syndrome in the course of COVID-19. TH Open. 2020;4(3):e207–e210. doi:https://doi.org/10.1055/s-0040-1716735.
- Mantovani Cardoso E, Hundal J, Feterman D, et al. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol. 2020;39(9):2811–2815. doi:https://doi.org/10.1007/s10067-020-05310-1.
- Frankel M, Feldman I, Levine M, et al. Bilateral adrenal hemorrhage in coronavirus disease 2019 patient: a case report. J Clin Endocrinol Metab. 2020;105(12). doi:https://doi.org/10.1210/clinem/dgaa487.
- Smatti MK, Cyprian FS, Nasrallah GK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. doi:https://doi.org/10.3390/v11080762.
- Magdi M, Rahil A. Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature review. Eur J Case Rep Intern Med. 2019;6(7):001155. doi:https://doi.org/10.12890/2019_001155.
- Lo AW, Tang NL, To KF. How the SARS coronavirus causes disease: host or organism? J Pathol. 2006;208(2):142–151. doi:https://doi.org/10.1002/path.1897.
- Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle East Respiratory Syndrome. J Clin Neurol (Seoul, Korea). 2017;13(3):227–233. doi:https://doi.org/10.3988/jcn.2017.13.3.227.
- Li Q, Cao Y, Chen L, et al. Hematological features of persons with COVID-19. Leukemia. 2020;34(8):2163–2172. doi:https://doi.org/10.1038/s41375-020-0910-1.
- Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020;99(7):1421–1428. doi:https://doi.org/10.1007/s00277-020-04103-5.
- Abou-Ismail MY, Diamond A, Kapoor S, et al. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020;194:101–115. doi:https://doi.org/10.1016/j.thromres.2020.06.029.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:https://doi.org/10.1056/NEJMoa2002032.
- Zhang Y, Zeng X, Jiao Y, et al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020;193:110–115. doi:https://doi.org/10.1016/j.thromres.2020.06.008.
- Pavord S, Thachil J, Hunt BJ, et al. Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic. Br J Haematol. 2020;189(6):1038–1043. doi:https://doi.org/10.1111/bjh.16775.
- Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2020. doi:https://doi.org/10.1159/000512007.
- Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020:1–11. doi:https://doi.org/10.1007/s42399-020-00521-8.
- Andrès E, Fothergill H, Mecili M. Life-threatening autoimmune hematological disorders. In: Khamashta MA, Ramos-Casals M, editors. Autoimmune diseases: acute and complex situations. London: Springer London; 2011. p. 259–273.
- Khan AM, Mydra H, Nevarez A. Clinical practice updates in the management of immune thrombocytopenia. P & T. 2017;42(12):756–763.
- Wei Y, Ji X-b, Wang Y-w, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127(3):296–302.
- Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. doi:https://doi.org/10.1186/1710-1492-9-30.
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–186. doi:https://doi.org/10.1182/blood-2009-06-225565.
- Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:https://doi.org/10.1007/s00134-020-06062-x.
- King KE, Ness PM. Treatment of autoimmune hemolytic anemia. Semin Hematol. 2005;42(3):131–136. doi:https://doi.org/10.1053/j.seminhematol.2005.04.003.